Allogeneic vs. autologous mesenchymal stem/stromal cells in their medication practice

Cell & Bioscience

Bin Wang¹  Linna Cheng²  Hua Zhao³  Chenghai Li⁴ 

[1] Department of Neurosurgery, People’s Hospital of Zhengzhou University;Institute of Hematology, People’s Hospital of Zhengzhou University;Institute of Reproductive Medicine, People’s Hospital of Zhengzhou University;Stem Cell Program of Clinical Research Center, People’s Hospital of Zhengzhou University;

关键词: Mesenchymal stem/stromal cell;    Single-nucleotide polymorphism;    Stem cell heterogeneity;    Stem cell microenvironment;    Stem cell transplantation;   

DOI  :  10.1186/s13578-021-00698-y

来源: DOAJ

【 摘 要 】

Abstract Mesenchymal stem/stromal cell (MSC)-based therapeutics is already available for treatment of a range of diseases or medical conditions. Autologous or allogeneic MSCs obtained from self or donors have their own advantages and disadvantages in their medical practice. Therapeutic benefits of using autologous vs. allogeneic MSCs are inconclusive. Transplanted MSCs within the body interact with their physical microenvironment or niche, physiologically or pathologically, and such cells in a newly established tissue microenvironment may be impacted by the pathological harmful environmental factors to alter their unique biological behaviors. Meanwhile, a temporary microenvironment/niche may be also altered by the resident or niche-surrounding MSCs. Therefore, the functional plasticity and heterogeneity of MSCs caused by different donors and subpopulations of MSCs may result in potential uncertainty in their safe and efficacious medical practice. Acknowledging a connection between MSCs’ biology and their existing microenvironment, donor-controlled clinical practice for the long-term therapeutic benefit is suggested to further consider minimizing MSCs potential harm for MSC-based individual therapies. In this review, we summarize the advantages and disadvantages of autologous vs. allogeneic MSCs in their therapeutic applications. Among other issues, we highlight the importance of better understanding of the various microenvironments that may affect the properties of niche-surrounding MSCs and discuss the clinical applications of MSCs within different contexts for treatment of different diseases including cardiomyopathy, lupus and lupus nephritis, diabetes and diabetic complications, bone and cartilage repair, cancer and tissue fibrosis.

【 授权许可】

Unknown